Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical

Suzhou Tianji Bio-Pharmaceutical, a subsidiary of Suzhou Tianma Pharma Group, is a leading Chinese biotechnology company specializing in the research, development, and commercialization of peptide therapeutics. Established in 2000, the company has built a robust infrastructure for large-scale peptide synthesis, purification, and lyophilization, operating under stringent international GMP standards. Their product portfolio encompasses a wide range of peptide APIs and finished injectable dosages targeting metabolic diseases, reproductive health, and oncology. Tianji Bio-Pharmaceutical is recognized for its technical expertise in complex peptide chemistry and serves as a key CDMO partner for global pharmaceutical firms. The company's facilities have successfully passed inspections by the US FDA, demonstrating their commitment to high-quality manufacturing for international markets.